UroGen Pharma (URGN) Receivables - Net (2016 - 2026)
UroGen Pharma's Receivables - Net came in at $88.76 million for Q2 2026, up 351.7% from $19.65 million a year earlier and up 60.2% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Receivables - Net (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Receivables - Net was $33.08 million, up 62.9% from FY2024.
- Receivables - Net has increased in each of the last five years, with a five-year compound annual growth rate of 36.2% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $20.3 million in FY2024 (+31.5%), $15.44 million in FY2023 (+21.6%), $12.7 million in FY2022 (+8.4%) and $11.72 million in FY2021 (+66.3%).
- The Q2 2026 figure represents the highest quarterly Receivables - Net in data going back to Q4 2016.
- Year-over-year, Receivables - Net has increased for three consecutive quarters, with growth averaging 93.0% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q2 2026 (growth of 351.7%), and the weakest in Q3 2025 (a decline of 13.6%).
- Business Quant data shows URGN's Receivables - Net at $55.41 million (Q1 2026), $33.08 million (Q4 2025) and $19.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | UroGen Pharma | 1.79 Bn | 1.29 Bn | 65.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.76 Mn |
| Mar 31, 2026 | 55.41 Mn |
| Dec 31, 2025 | 33.08 Mn |
| Sep 30, 2025 | 19.70 Mn |
| Jun 30, 2025 | 19.65 Mn |
| Mar 31, 2025 | 19.64 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 14.16 Mn |
| Dec 31, 2023 | 15.44 Mn |
| Sep 30, 2023 | 12.85 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Mar 31, 2023 | 12.49 Mn |
| Dec 31, 2022 | 12.70 Mn |
| Sep 30, 2022 | 9.43 Mn |
| Jun 30, 2022 | 11.60 Mn |
| Mar 31, 2022 | 9.50 Mn |
| Dec 31, 2021 | 11.72 Mn |
| Sep 30, 2021 | 7.78 Mn |
API Access
UroGen Pharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();